During the past decade, Klinikum Südstadt Rostock conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Südstadt Rostock" #1 sponsor was "German Breast Group" with 3 trials, followed by "AGO Study Group" with 2 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AGO Research GmbH" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Südstadt Rostock" #1 collaborator was "Bayer" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Analyze & Realize" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Südstadt Rostock" are "Ovarian Cancer" (5 trials), "Breast Cancer" (3 trials), "Fallopian Tube Cancer" (2 trials), "Lymphoma" (2 trials) and "Adult-Onset Still´s Disease" (1 trials). Many other conditions were trialed in "Klinikum Südstadt Rostock" in a lesser frequency.

Most popular intervention types in "Klinikum Südstadt Rostock" are "Drug" (20 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials), "cyclophosphamide" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Südstadt Rostock" are 13 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Südstadt Rostock". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Klinikum Südstadt Rostock, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Südstadt Rostock, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Klinikum Südstadt Rostock has several departments that took part in Clinical trials: "Klinikum Südstadt Rostock, Innere Medizin III" - 2 trials